180 related articles for article (PubMed ID: 2466371)
1. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.
Portetelle D; Dandoy C; Burny A; Zavada J; Siakkou H; Gras-Masse H; Drobecq H; Tartar A
Virology; 1989 Mar; 169(1):34-41. PubMed ID: 2466371
[TBL] [Abstract][Full Text] [Related]
2. Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.
Callebaut I; Burny A; Krchnák V; Gras-Masse H; Wathelet B; Portetelle D
Virology; 1991 Nov; 185(1):48-55. PubMed ID: 1718088
[TBL] [Abstract][Full Text] [Related]
3. Antigenic variants of bovine leukemia virus (BLV) are defined by amino acid substitutions in the NH2 part of the envelope glycoprotein gp51.
Portetelle D; Couez D; Bruck C; Kettmann R; Mammerickx M; Van der Maaten M; Brasseur R; Burny A
Virology; 1989 Mar; 169(1):27-33. PubMed ID: 2466370
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51.
Bruck C; Mathot S; Portetelle D; Berte C; Franssen JD; Herion P; Burny A
Virology; 1982 Oct; 122(2):342-52. PubMed ID: 6183819
[No Abstract] [Full Text] [Related]
5. Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability.
Bruck C; Rensonnet N; Portetelle D; Cleuter Y; Mammerickx M; Burny A; Mamoun R; Guillemain B; van der Maaten MJ; Ghysdael J
Virology; 1984 Jul; 136(1):20-31. PubMed ID: 6204449
[TBL] [Abstract][Full Text] [Related]
6. In animals infected by bovine leukemia virus (BLV) antibodies to envelope glycoprotein gp51 are directed against the carbohydrate moiety.
Portetelle D; Bruck C; Mammerickx M; Burny A
Virology; 1980 Aug; 105(1):223-33. PubMed ID: 6158161
[No Abstract] [Full Text] [Related]
7. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.
Callebaut I; Vonèche V; Mager A; Fumière O; Krchnak V; Merza M; Zavada J; Mammerickx M; Burny A; Portetelle D
J Virol; 1993 Sep; 67(9):5321-7. PubMed ID: 7688821
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and immunological characterization of the bovine leukemia virus (BLV) envelope glycoprotein (gp51) produced in Saccharomyces cerevisiae.
Legrain M; Portetelle D; Dumont J; Burny A; Hilger F
Gene; 1989 Jul; 79(2):227-37. PubMed ID: 2551774
[TBL] [Abstract][Full Text] [Related]
9. Elicitation of bovine antibody to BLV-gp51 by BLV-vaccination.
Maruyama K; Fukushima T; Mochizuki S; Abe H; Onuma M; Hasegawa A; Misawa M
Leukemia; 1988 Dec; 2(12 Suppl):216S-222S. PubMed ID: 2848999
[TBL] [Abstract][Full Text] [Related]
10. Bovine monoclonal antibody to bovine leukemia virus glycoprotein GP51 from bovine-murine hybridoma.
Tanaka M; Okabe T; Sasaki N
Nihon Juigaku Zasshi; 1988 Oct; 50(5):1136-8. PubMed ID: 2848966
[No Abstract] [Full Text] [Related]
11. Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.
Bai L; Otsuki H; Sato H; Kohara J; Isogai E; Takeshima SN; Aida Y
Retrovirology; 2015 Dec; 12():106. PubMed ID: 26715158
[TBL] [Abstract][Full Text] [Related]
12. Production of monoclonal antibody to bovine leukemia virus glycoprotein gp51 by in vitro immunization.
Sasaki O; Tanaka M; Okabe T; Imanishi J
Microbiol Immunol; 1990; 34(4):401-5. PubMed ID: 2163485
[TBL] [Abstract][Full Text] [Related]
13. Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.
Ban J; Czene S; Altaner C; Callebaut I; Krchnak V; Merza M; Burny A; Kettmann R; Portetelle D
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2457-61. PubMed ID: 1383413
[TBL] [Abstract][Full Text] [Related]
14. Topographical analysis by monoclonal antibodies of BLV-gp51 epitopes involved in viral functions.
Bruck C; Portetelle D; Burny A; Zavada J
Virology; 1982 Oct; 122(2):353-62. PubMed ID: 6183820
[No Abstract] [Full Text] [Related]
15. Identification of an immunodominant region on the isolated bovine leukaemia virus (BLV) major envelope protein gp51 by monoclonal antibodies presumably not exposed during natural BLV infection.
Platzer C; Siakkou H; Sober J; Kopp J; Scheve E; Rosenthal S
Acta Virol; 1990 May; 34(3):246-55. PubMed ID: 1980398
[TBL] [Abstract][Full Text] [Related]
16. Immunoaffinity purification of two major proteins of bovine leukemia virus (gp51 and p24) and their use for discrimination between vaccinated and infected animals.
Merza M; Sundquist B; Söber J; Morein B
J Virol Methods; 1991 Aug; 33(3):345-53. PubMed ID: 1723735
[TBL] [Abstract][Full Text] [Related]
17. Development of a specific serological test and an efficient subunit vaccine to control bovine leukemia virus infection.
Portetelle D; Burny A; Desmettre P; Mammerickx M; Paoletti E; Zavada J
Dev Biol Stand; 1990; 72():81-90. PubMed ID: 1704325
[TBL] [Abstract][Full Text] [Related]
18. Epitopes of bovine leukemia virus glycoprotein gp51 recognized by sera of infected cattle and sheep.
Bruck C; Portetelle D; Mammerickx M; Mathot S; Burny A
Leuk Res; 1984; 8(3):315-21. PubMed ID: 6205222
[TBL] [Abstract][Full Text] [Related]
19. Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51.
Portetelle D; Mammerickx M; Burny A
J Virol Methods; 1989 Feb; 23(2):211-22. PubMed ID: 2542354
[TBL] [Abstract][Full Text] [Related]
20. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
